AAAAAA

   
Results: 1-8 |
Results: 8
RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASEIS HETEROGENEOUS
Authors: WILSON JE WRIGHT LL MARTIN JL HAIRE SE RAY PH PAINTER GR FURMAN PA
Citation: Je. Wilson et al., RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASEIS HETEROGENEOUS, Journal of acquired immune deficiency syndromes and human retrovirology, 11(1), 1996, pp. 20-30
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - CONTRIBUTION OF MET-184 TO BINDING OF NUCLEOSIDE 5'-TRIPHOSPHATE
Authors: WILSON JE AULABAUGH A CALIGAN B MCPHERSON S WAKEFIELD JK JABLONSKI S MORROW CD REARDON JE FURMAN PA
Citation: Je. Wilson et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - CONTRIBUTION OF MET-184 TO BINDING OF NUCLEOSIDE 5'-TRIPHOSPHATE, The Journal of biological chemistry, 271(23), 1996, pp. 13656-13662
THE EFFECT OF ABSOLUTE-CONFIGURATION ON THE ANTI-HIV AND ANTI-HBV ACTIVITY OF NUCLEOSIDE ANALOGS
Authors: FURMAN PA WILSON JE REARDON JE PAINTER GR
Citation: Pa. Furman et al., THE EFFECT OF ABSOLUTE-CONFIGURATION ON THE ANTI-HIV AND ANTI-HBV ACTIVITY OF NUCLEOSIDE ANALOGS, Antiviral chemistry & chemotherapy, 6(6), 1995, pp. 345-355
EVALUATION OF THE POTENT ANTI-HEPATITIS-B VIRUS AGENT -1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE IN A NOVEL IN-VIVO MODEL
Authors: CONDREAY LD JANSEN RW POWDRILL TF JOHNSON LC SELLESETH DW PAFF MT DALUGE SM PAINTER GR FURMAN PA ELLIS MN AVERETT DR
Citation: Ld. Condreay et al., EVALUATION OF THE POTENT ANTI-HEPATITIS-B VIRUS AGENT -1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE IN A NOVEL IN-VIVO MODEL, Antimicrobial agents and chemotherapy, 38(3), 1994, pp. 616-619
THE 5'-TRIPHOSPHATES OF THE (-) AND 1-2-(HYDROXYMETHYL)-1,3-OXATHIOLANE-5-YL!CYTOSINE EQUALLY INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE() ENANTIOMERS OF CIS)
Authors: WILSON JE MARTIN JL BORROTOESODA K HOPKINS S PAINTER G LIOTTA DC FURMAN PA
Citation: Je. Wilson et al., THE 5'-TRIPHOSPHATES OF THE (-) AND 1-2-(HYDROXYMETHYL)-1,3-OXATHIOLANE-5-YL!CYTOSINE EQUALLY INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE() ENANTIOMERS OF CIS), Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1720-1722
PHARMACOKINETICS, ORAL BIOAVAILABILITY, AND METABOLIC DISPOSITION IN RATS OF 5-FLUORO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL] CYTOSINE, ANUCLEOSIDE ANALOG ACTIVE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS AND HEPATITIS-B VIRUS
Authors: FRICK LW STJOHN L TAYLOR LC PAINTER GR FURMAN PA LIOTTA DC FURFINE ES NELSON DJ
Citation: Lw. Frick et al., PHARMACOKINETICS, ORAL BIOAVAILABILITY, AND METABOLIC DISPOSITION IN RATS OF 5-FLUORO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL] CYTOSINE, ANUCLEOSIDE ANALOG ACTIVE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS AND HEPATITIS-B VIRUS, Antimicrobial agents and chemotherapy, 37(11), 1993, pp. 2285-2292
MECHANISM OF RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO 2',3'-DIDEOXYINOSINE
Authors: MARTIN JL WILSON JE HAYNES RL FURMAN PA
Citation: Jl. Martin et al., MECHANISM OF RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO 2',3'-DIDEOXYINOSINE, Proceedings of the National Academy of Sciences of the United Statesof America, 90(13), 1993, pp. 6135-6139
IDENTIFICATION OF THE NUCLEOTIDE-BINDING SITE OF HIV-1 REVERSE-TRANSCRIPTASE USING DTTP AS A PHOTOAFFINITY LABEL
Authors: CHENG N MERRILL BM PAINTER GR FRICK LW FURMAN PA
Citation: N. Cheng et al., IDENTIFICATION OF THE NUCLEOTIDE-BINDING SITE OF HIV-1 REVERSE-TRANSCRIPTASE USING DTTP AS A PHOTOAFFINITY LABEL, Biochemistry, 32(30), 1993, pp. 7630-7634
Risultati: 1-8 |